Homocysteine in plasma by LC/MS 100 test

Homocysteine  in plasma by LC/MS code  LC09010)

INSIGHTS
Homocysteine (HCY) is a sulfurated aminoacid that derives from the demethylation of Methionine. Homocysteine is considered an independent risk factor, because it is able to increase the incidence of cardiovascular diseases independently of the presence of other causing factors. It also increases the risk of other pathologies (venous thrombosis, pulmonary embolism) as well as fetal malformations, mental decay, Alzheimer and spontaneous fractures. Folates, B12 and B6 Vitamins intake can be successfully used in different forms of hyperhomocysteinemia. For this reason, an early diagnosis is fundamental to avoid the risk of cardiac and cerebrovascular thrombotic diseases.

Principle of the Method:

Homocysteine is analyzed by treating the plasma with a suitable reducing agent. After deproteinization, the solution is directly injected into the LC / MS

	IFU
	IFU MOBILE PHASE M 1
	IFU MOBILE PHASE M 2